Infervision is a leading AI medical technology company established in 2016. With a focus on improving multi-disciplinary services and operations with AI, Infervision helps healthcare providers in three key areas: disease screening and diagnosis, patient treatment and management, research and development.

Adopting a vertical and horizontal product strategy, Infervision offers a comprehensive series of AI-assisted software to detect a wide range of anomalies such as cancers, infectious diseases, cardiovascular diseases, cerebrovascular diseases and trauma and more. Alongside existing disease screening and diagnosis (InferRead®), intervention and treatment (InferOperate®), patient health management (InferCare®), and teaching and research initiatives (InferScholar®, InferMartrix, InferEducate), Infervision is the trusted partner for hospitals, other medical institutions, governments, doctors and patients across the globe.